Standard Vs Supralabial Bispectral Index Scores
Comparative Study Between Standard Vs Supralabial Bispectral Index Scores
1 other identifier
observational
50
1 country
1
Brief Summary
With the rise in number of surgeries, the medicolegal issues are on rise especially if patient had intraoperative awareness, which can also be detrimental to psychosocial behaviour of patient. Investigators plan to compare the BIS values, 'which is an indicator of awareness', from supralabial to standard forehead placement sites. If the results are corroborative then the supralabial site can be used for BIS monitoring in neurosurgical cases where it is not possible to to apply the forehead BIS strips.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2019
CompletedStudy Start
First participant enrolled
January 20, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2020
CompletedFebruary 18, 2020
February 1, 2020
2 months
November 12, 2019
February 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraoperative BIS values
the values from both sites will be monitored
from induction of anaesthesia till surgery is over upto 5 hours
Study Arms (1)
Anaesthetised patients
50 patients undergoing robotic surgeries under general anesthesia
Interventions
Bis value from two sites gives similar results
Eligibility Criteria
Patients of all genders of all age and BMI
You may qualify if:
- Age group: 18-65 yrs
- ASA status: 1-3
- Use of endotracheal tube for securing the airway
You may not qualify if:
- Facial deformity : scars, cleft lip, mole etc
- Presence of beard and moustache
- Use of supraglottic device
- Patient under regional anaesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rajiv Gandhi Cancer Institute & Research Centre
New Delhi, National Capital Territory of Delhi, 110085, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Anaesthesia, Principle investigator
Study Record Dates
First Submitted
November 12, 2019
First Posted
February 5, 2020
Study Start
January 20, 2020
Primary Completion
April 1, 2020
Study Completion
May 1, 2020
Last Updated
February 18, 2020
Record last verified: 2020-02